Work

Abstract 4457: A novel CerS2 activator, DH20931, synergizes with doxorubicin to overcome therapeutic resistance in breast cancer.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-4457

Authors: Hissah Alatawi, Haritha H. Nair, Lingbao Ai, Abhisheak Sharma, Christopher Vulpe, Arun K. Sharma, Coy D. Heldermon, Satya Narayan

Institutions: University of Florida, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148672068

Cites:

Cited by:

Related to: